Ascend Advanced Therapies, an end-to-end gene therapy development partner, has added industry veteran Scott Law as Chief Operations Officer (COO).   Law joins an experienced leadership team that includes expertise in gene therapy from the development and services side with the goal of streamlining operational excellence as Ascend evolves.   Law brings more than 30 years of global pharmaceutical experience, including senior manufacturing roles at companies such as Telix Pharmaceuticals, Baxte...